SALT LAKE CITY, May 22 /PRNewswire/ -- Amedica Corporation today announced that it has filed a registration statement with the Securities and Exchange Commission (SEC) on Form S-1 for the proposed initial public offering of its common stock. All the offered shares will be sold by the Company. Amedica plans to list its common stock on the NASDAQ Global Market under the symbol AMCA.
Morgan Stanley & Co. Incorporated will act as sole bookrunning manager for the offering. Jefferies & Company, Inc. and CIBC World Markets Corp. will act as co-lead managers. When available, prospectuses may be obtained by contacting Morgan Stanley & Co. Incorporated, 180 Varick Street, 2nd Floor, New York, New York 10014, attention: Prospectus Department, 866-718-1649, or by e-mailing firstname.lastname@example.org.
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to their registration or qualification under the securities laws of any such state or jurisdiction.
About Amedica Corporation
Amedica Corporation is an orthopedic implants company focused on using its silicon nitride ceramic technologies to develop, manufacture and commercialize a broad range of advanced, high-performance spine and joint implants.
Source: Amedica Corporation